Jun 22, 2020
CrazyCap helps Martine Rothblatt Cheer On Her Team Through Crisis!
Jun 17, 2020
United Therapeutics Announces Increase Data Presentation at an American Thoracic Society Virtual Session
Jun 05, 2020
United Therapeutics Corporation Files Lawsuit Against Liquidia For Infringement Of Tyvaso Patents
May 19, 2020
Small Cell Lung Cancer (SCLC) Market Insights, Epidemiology and Forecast to 2030
May 06, 2020
United Therapeutics Corporation To Present At The BofA Securities Virtual Health Care Conference 2020
Apr 29, 2020
United Therapeutics Corporation Reports First Quarter 2020 Financial Results
Apr 27, 2020
Global Osteosarcoma Pipeline Insights, H1 2020: Therapeutics, Developments, Products, Drugs, Players
Apr 23, 2020
United Therapeutics Announces Additional Results From FREEDOM-EV Study Showing The Hemodynamic And Risk Status Reduction Benefits Of Orenitram Treatment In Patients With Pulmonary Arterial Hypertension
Apr 22, 2020
United Therapeutics Corporation to Report First Quarter 2020 Financial Results Before the Market Opens on Wednesday, April 29, 2020
Apr 06, 2020
The Global Pulmonary Arterial Hypertension Market is expected to grow from USD 7,196.48 Million in 2019 to USD 9,925.12 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.50%
Mar 24, 2020
Pipeline Insights of Bronchopulmonary Dysplasia, H1 2020: Therapeutics Assessment, Drug Profiles, Companies Involved
Mar 05, 2020
Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report By Drug Class And Segment Forecasts, 2020 - 2027
Feb 26, 2020
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2019 Financial Results
Feb 25, 2020
United Therapeutics Corporation To Present At The 40th Annual Cowen And Company Healthcare Conference
Feb 24, 2020
United Therapeutics and DEKA Announce Additional FDA Clearance Related to the Unity Subcutaneous Delivery System for Remodulin®
Feb 24, 2020
United Therapeutics Announces INCREASE Study Of Tyvaso® Meets Primary And All Secondary Endpoints
Feb 20, 2020
Small Cell Lung Cancer Market Size is Expected to Increase at a CAGR of 13.2% for the Study Period (2017-2030) in the 7MM | Some Market Key Players - AstraZeneca, PharmaMar, EpicentRx, United Therapeutics, Ipsen, G1 Therapeutics, Otsuka Holdings, Takeda
Feb 04, 2020
United Therapeutics Defeats Preliminary Injunction Motion In Litigation With Sandoz And RareGen
Feb 03, 2020
United Therapeutics Announces Study of Unituxin® (dinutuximab) for Small Cell Lung Cancer Did Not Meet Primary Endpoint
Jan 15, 2020
Visiongain Publishes Global Pulmonary Arterial Hypertension Market 2019-2029 Report